GSK's Q2 earnings and revenues top forecasts, with Specialty Medicines and Vaccines driving growth and a raised 2025 outlook boosting shares.

BAE Systems also came under pressure, falling 24p to 1797p despite its upgrade to 2025 guidance. GSK also surrendered initial ...

British pharmaceutical giant GSK Plc (NYSE:GSK) shares rose on Wednesday after reporting second-quarter results that surpassed analyst expectations and led the company to raise its full-year 2025 ...

Rolls-Royce today lifted full year guidance after reporting a 50% increase in underlying operating profit to £1.7 billion for ...

FTSE 100 reaction as HSBC sees profits drop, Nationwide launches benefits line - Stock market news and latest business and finance updates from Wednesday ...

The FTSE 100 index closed up just 0.62 of a point at 9,136.94. The FTSE 250 closed 16.49 points lower, 0.1%, at 21,776.58, and the AIM All-Share closed down 3.03 points, 0.4%, at 762.72.

The latest Market Talks covering the Health Care sector. Published exclusively on Dow Jones Newswires at 4:20 ET, 12:20 ET ...

Harley-Davidson Shares Jump on Cash Infusion From KKR, Pimco Partnership Harley-Davidson shares jumped after the motorcycle maker said it would pay off debt and accelerate share repurchases with cash ...

GSK's GSK +0.59% Get Free Report short percent of float has fallen 27.17% since its last report. The company recently reported that it has 13.51 million shares sold short, which is 0.67% of all ...

GSK PLC GSK shares rose 4.69% to £14.63 Wednesday, on what proved to be an all-around favorable trading session for the stock ...

GSK (LSE: GSK) posted a 6% rise in second-quarter sales to £8 billion ($10.7 billion), ahead of analyst forecasts. Pre-tax ...

British consumer healthcare group Haleon lowered its annual revenue growth forecast to about 3.5% on Thursday after ...